45

DAFTAR PUSTAKA

Aberg, J.A., Lacy, C., Amstrong, L., Goldman, M. and Lance, L.L., 2009,
Drug Information Handbook 17th Edition, American
PharmacistAssociation.
Alldredge, B.K., Corelli, R.L. and Ernst, M.E., 2013, Koda Kimble
andYoung’s Applied Therapeutics: The Clinical Use of
Drugs,Lippincott Williams & Wilkins.
Baxter K., 2008, Stockley’s Drug Interactions 8th Edition, London.
BNF, 2009, British National Formulary, Edisi 57, British
MedicalAssociation Royal Pharmacetical of Great Britain,
England.
Cowie, M.R., Dar, Q, 2008,The Epidemiology and Diagnosis of Heart
Failure. In: Fuster, V., et al., eds. Hurst’s the Heart. 12th ed.
Volume 1. USA: McGraw-Hill.
Dipiro, J.T.,Wells, B.G., andSchwinghammer, T.L., 2008,
th
Pharmacotherapy: A Patophysiologic Approach,7 edition, Mc.
Graw Hill Medical, New York.
DiPiro, J.T., Wells, B.G., andSchwinghammer, T.L., 2015,
Pharmacotherapy: A Patophysiologic Approach (9th
edition),Mc.Graw Hill, New York.

Drug interaction checker, terdapat di: http://www.drugs.com

Drug interaction checker, terdapat di: http://www.medscape.com

Gabay M., 2015, The Clinical Practice of Drug Information, Jones and
Bartlett Publisher, Chicago, United States of America.

Gitawati, R., 2008, Interaksi Obat dan Beberapa Implikasinya, Puslitbang

Biomedis dan Farmasi, Badan Litbangkes, Media Litbang
Kesehatan Volume XVIII.

45
 46

Ito K, Iwatsubo T, Kanamitsu S, et al., 1998, Prediction of

pharmacokinetic alterations caused by drug-drug interactions:
Metabolic interaction in the liver. Pharm Rev; 50 (3):387-411.
Kafeel, H., Rukh, R., Qamar, H., Bawany, J., Jamshed, M., Sheikh, R., et
al., 2014, Possibility of Drug-Drug Interaction in Prescription
Dispensed by Community and Hospital Pharmacy, pharmacology
and Pharmacy., 5,pp.403-404.
Mann D.L., 2008,Pathophysiology of Heart Failure. In: Braunwald’s
Heart Disease, 8th ed, Saunders. 541-560.
Marcus NJ, Li YL, Bird CE, Schultz HD, Morgan BJ, 2014, Chronic
intermittent hypoxia augments chemoreflex control of sympathetic
activity: role of the angiotensin II type 1 receptor. Respir Physiol
Neurobiol. ;171:36–45, [PMC free article] [PubMed].
Menteri Kesehatan Republik Indonesia, 2014, Peraturan Menteri
Kesehatan Republik Indonesia Nomor 35 tahun 2014 Tentang
Standar Pelayanan Kefarmasian di Apotek, Jakarta.
Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al., 2013, Heart
disease and stroke statistics 2013 update : a report from the
American Heart Association. Circulation, pp.127:e6-e245.
Moura C, Acurcio F, Belo N. Drug-drug interactions associated with
length of stay and cost of hospitalization. J Pharm Pharmaceut
Sci 2009; 12: 266-72.
Rantucci, M.J. 2007. Komunikasi Apoteker-Pasien Edisi 2, Penerbit
Kedokteran EGC,Jakarta
Rama, M., Viswanathan, G., and Attur, R. P., 2012, Assessment of Drug-
Drug Interactions among Renal Failure Patients of Nephrology
Ward in a South Indian Tertiary Care Hospital. Indian J Pharm
Sci., 74(1) pp.63–68.
Riset Kesehatan Dasar, 2013, Badan Penelitian dan
PengembanganKesehatan, Departemen Kesehatan Republik
Indonesia, Jakarta.
 47

Sevilla, C.G., Ochave, J.A., Punsalan, T.G., and Regala, B.P., 2007,
Research Methods, Quezon City (PH), Rex Printing Company.
Sukandar, E.Y., Andrajati, R., Sigit, J.I., Adnyana, I.K., Setiadi, A.A.P.,
Kusnandar, 2008, Iso Farmakoterapi, P.T. ISFI Penerbitan,
Jakarta.
Sulistiyowatiningsih, E., Hidayati, S.N. dan Febrianti, Y., 2016,
KajianInteraksi Obat Pada Pasien Gagal Jantung Dengan
Gangguan Fungsi Ginjal Di Instalasi Rawat Inap RSUP DR.
Sardjito Yogyakarta Periode 2009-2013, Farmasi Universitas
Islam Indonesia, Yogyakarta.
Snyder, B., Polasek, T., Doogue, M., 2012. Drug interactions : principles
and practice, 35, 85–88.
Tatro, D.S., 2012, Drug Interaction Facts 2012, edisi 6, Fact and
Comparissons, A. Wolter Klowers, St. Louis.
Vonbach P, Dubied A, Krähenbühl S, et al., 2008, Prevalence of drug-
drug interactions at a hospital entry and during hospital stay of
patients in internal medicine,Eur J Int Med, 19: 413-20.
Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E., and
Drazner, M.H, 2013,ACCF/AHA Guideline for the management
of heart failure, American College of Cardiology Foundation,
128:e240-e327.
Yasin, N.M., Widyastuti, T.H., Dewi, K.E., 2008, Kajian Interaksi Obat
pada Pasien Gagal Jantung Kongestif di RSUP DR. Sardjito
Yogyakarta Tahun 2005, Bagian Farmakologi dan Farmasi
Klinik, Fakultas Farmasi Universitas Gadjah Mada.